Jushi Holdings Refinances $132M Debt to 2029, Reports Mixed Q4/FY25 Results, & Notes Virginia Adult-Use Progress
JUSHF has more than doubled off its 52-week low of $0.233.
Summary
Jushi Holdings reported mixed Q4/FY25 results, but significantly strengthened its balance sheet by refinancing $132.3 million in debt to 2029 and noted positive progress on Virginia adult-use cannabis legislation.
Key Events · Financing and Capital Events · JUSHF
-
Significant Debt Refinancing Completed
In March 2026, Jushi refinanced approximately $132.3 million of existing senior secured term loan and second lien notes with a new $160.0 million 12.5% secured term loan due in 2029. This transaction extends debt maturities and enhances liquidity, with participation from the CEO and a significant equity holder.
-
Mixed Q4 and Full Year 2025 Financial Results
For Q4 2025, revenue increased 3.8% year-over-year to $68.3 million, and Adjusted EBITDA surged 74.0% to $13.9 million. However, the net loss widened to $15.6 million. For the full year 2025, revenue grew 2.1% to $262.9 million, but net loss increased to $68.6 million, while Adjusted EBITDA improved 8.8% to $50.3 million.
-
Virginia Adult-Use Cannabis Legislation Progress
The Virginia General Assembly passed adult-use cannabis legislation, establishing a regulated retail market with sales projected to begin January 1, 2027, subject to the Governor's approval. This represents a substantial potential market expansion for Jushi, which has existing infrastructure in the state.
Analysis · JUSHF · Life Sciences
Jushi Holdings Inc. announced its fourth quarter and full year 2025 financial results, which showed mixed performance with modest revenue growth and a wider net loss, but significant improvement in Q4 Adjusted EBITDA. Crucially, the company also disclosed a major post-quarter-end debt refinancing, extending maturities to 2029 and enhancing liquidity. This refinancing, which saw participation from the CEO and a significant equity holder, addresses a substantial portion of the company's debt relative to its market capitalization. Additionally, the passing of Virginia adult-use cannabis legislation by the General Assembly, pending Governor's approval, presents a significant future growth opportunity for Jushi, which operates in the state. These strategic financial and regulatory developments are highly important for the company's long-term stability and growth prospects.
At the time of this filing, JUSHF was trading at $0.51 on OTC in the Life Sciences sector, with a market capitalization of approximately $99.4M. The 52-week trading range was $0.23 to $0.98. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.